VIRS
Pacer BioThreat Strategy ETF
VIRS
VIRS
Delisted
VIRS was delisted on the 10th of October, 2024.
3 hedge funds and large institutions have $1.47M invested in Pacer BioThreat Strategy ETF in 2023 Q2 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$265K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$18.3K |
Top Sellers
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$2.99K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$234 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Royal Bank of Canada
Toronto,
Ontario, Canada
| $554K | +$265K | +8,500 | +92% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $527K | +$18.3K | +586 | +4% |
|
|
3
Osaic Holdings
Scottsdale,
Arizona
| $390K | -$2.99K | -96 | -0.8% |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$234 | -8 | Closed |
|